Acceliant, the global leader in e-clinical data management solutions, has partnered with Turacoz, a leading medical communications company that provides customised, cost-effective solutions to the healthcare and pharmaceutical industries.
Turacoz will leverage its association with Acceliant to strengthen its technological capabilities in PMS, registry, observational and real-world evidence studies globally. The expanded use of Acceliant will also help Turacoz to extend a seamless product experience to its clients. Meanwhile, Acceliant now has a complete spectrum of end-to-end solutions and services (ranging from medical writing, clinical operations, data management, pharmacovigilance and publications) for late phase studies through this alliance.
“Our partnership with Acceliant will help us enable a unique complete solution offering for our clients. We expect to address some of the major industry challenges, such as operational efficiency and data integrity, with this collaboration,” Dr. Namrata Singh, Founder and Director of Turacoz, said in a statement. “We will work closely with Acceliant and establish a complete service spectrum for real-world evidence solutions and observational studies,” she added.
Prashant Bhavaraju, Chief Marketing Officer of Acceliant, said, “Acceliant is really delighted to expand its partnership with Turacoz. Our e-clinical suite for pharma and medical devices companies, and CROs is a battle-tested platform; also one of the most highly advanced and smart EDC products in the market today. With this partnership, we will be able to give a one-stop experience to our clients.”
